(NASDAQ: DBVT) Dbv Technologies Sa's forecast annual revenue growth rate of 63.14% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 58.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.77%.
Dbv Technologies Sa's revenue in 2025 is $3,497,000.On average, 1 Wall Street analysts forecast DBVT's revenue for 2025 to be $423,172,014, with the lowest DBVT revenue forecast at $423,172,014, and the highest DBVT revenue forecast at $423,172,014. On average, 1 Wall Street analysts forecast DBVT's revenue for 2026 to be $465,626,165, with the lowest DBVT revenue forecast at $465,626,165, and the highest DBVT revenue forecast at $465,626,165.
In 2027, DBVT is forecast to generate $2,393,866,283 in revenue, with the lowest revenue forecast at $2,393,866,283 and the highest revenue forecast at $2,393,866,283.